Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation

Journal of Immunology

Volumn 183, Issue 11, 2009, Pages 7196-7203

  Filatenkov, Alexander ^a   Müller, Antonia M S ^a   Tseng, William Wei Lin ^a   Dejbakhsh Jones, Sussan ^a   Winer, Daniel ^a   Luong, Richard ^a   Shizuru, Judith A ^a   Engleman, Edgar G ^a   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR FOXP3; TUMOR CELL VACCINE; CANCER VACCINE; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER IMMUNIZATION; CARCINOMATOUS PERITONITIS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISSEMINATED CANCER; DRUG EFFICACY; DRUG TREATMENT FAILURE; EFFECTOR CELL; FEMALE; LIVER TUMOR; LUNG TUMOR; LYMPHOCYTIC INFILTRATION; MALE; MEMORY T LYMPHOCYTE; MOUSE; MYELOABLATIVE CONDITIONING; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PRIMARY TUMOR; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SOLID TUMOR; SPLEEN; SURVIVAL TIME; TUMOR GROWTH; TUMOR IMMUNITY; WHOLE BODY RADIATION; ANIMAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION; VACCINATION;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; MICE; NEOPLASMS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; VACCINATION; WHOLE-BODY IRRADIATION;

EID: 73349088735     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900159     Document Type: Article

References (24)

1. Finn, O. J. 2003. Cancer vaccines: between the idea and the reality. Nat. Rev. Immunol. 3: 630-641.
2. Rosenberg, S. A., and J. C. Yang. 2004. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10: 909-915.
3. Rosenberg, S. A., N. P. Restifo, J. C. Yang, R. A. Morgan, and M. E. Dudley. 2008. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 8: 299-308.
4. Huang, A.Y., P. H. Gulden, A. S. Woods, M. C. Thomas, C. D. Tong, W. Wang, V. H. Engelhard, G. Pasternack, R. Cotter, D. Hunt, et al. 1996. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc. Natl. Acad. Sci. USA 93: 9730-9735.
5. Slansky, J. E., F. M. Rattis, L. F. Boyd, T. Fahmy, E. M. Jaffee, J. P. Schneck, D. H. Margulies, and D. M. Pardoll. 2000. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity 13: 529-538.
6. McMahan, R. H., J. A. McWilliams, K. R. Jordan, S. W. Dow, D. B. Wilson, and J. E. Slansky. 2006. Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines. J. Clin. Invest. 116: 2543-2551.
7. McWilliams, J. A., R. T. Sullivan, K. R. Jordan, R. H. McMahan, C. B. Kemmler, M. McDuffie, and J. E. Slansky. 2008. Age-dependent tolerance to an endogenous tumor-associated antigen. Vaccine 26: 1863-1873.
8. Corbett, T. H., D. P. Griswold, and B. J. Roberts. 1975. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 35: 2434-2439.
9. 7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood 106: 4009-4015.
10. Spangrude, G. J., S. Heimfeld, and I. L. Weissman. 1998. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
11. Pillai, A. B., T. I. George, S. Dutt, P. Teo, and S. Strober. 2007. Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation. J. Immunol. 15. 178: 6242-6251.
12. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745. (Pubitemid 32015992)
13. Okano, F., M. Merad, K. Furumoto, and E. G Engleman. 2005. In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity. J. Immunol. 174: 2645-2652.
14. + cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J. Exp. Med. 201: 779-791.
15. Borrello, I., E. M. Sotomayor, F. Rattis, S. K. Cooke, L. Gu, and H. I. Levitsky. 2000. Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines. Blood 95: 3011-3019.
16. Mirmonsef, P., G. Tan, G. Zhou, T. Morino, K. Noonan, I. Borrello, and H. I. Levitsky. 2008. Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation. Blood 111: 2112-2121. (Pubitemid 351451523)
17. Meunier, M. C., J. S. Delisle, J. Bergeron, V. Rineau, C. Baron, and C. Perreault. 2005. T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat. Med. 11: 1222-1229.
18. Luznik, L., J. E. Slansky, S. Jalla, I. Borrello, H. I. Levitsky, D. M. Pardoll, and F. J. Fuchs. 2003. Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras. Blood 101: 1645-1652. (Pubitemid 36182546)
19. Childs, R., A. Chernoff, N. Contentin, E. Bahceci, D. Schrump, S. Lietman, E. J. Read, J. Tisdale, C. Dunbar, W. M. Linehan, et al. 2000. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N. Engl. J. Med. 343: 750-758.
20. Massenkeil, G. M., S. Nagy, S. Neuburger, I. Tamm, C. P. Lutz, O. le Coutre, O. Rosen, K.-D. Wernecke, B. Dörken, and R. Arnold. 2005. Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukemias. Bone Marrow Transplant. 36: 683-689.
21. Carnevale-Schianca, F., A. Cignetti, A. Capaldi, K. Vitaggio, A. Vallario, A. Ricchiardi, E. Sperti, R. Ferraris, M. Gatti, G. Grignan, et al. 2006. Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD. Blood 107: 3795-3803.
22. + T cells via TLR4 signaling. J. Clin. Invest. 117: 2197-2204.
23. Wrzesinski, C., C. M. Paulos, L. Gattinoni, D. C. Palmer, A. Kaiser, Z. Yu, S. A. Rosenberg, and N. P. Restifo. 2007. Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells. J. Clin. Invest. 117: 492-501.
24. + T-cell response. Nat. Rev. Immunol. 4: 595-602.